Fertility Disorders
78
16
18
36
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.1%
4 terminated out of 78 trials
90.0%
+3.5% vs benchmark
9%
7 trials in Phase 3/4
11%
4 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (78)
Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction
Strategies for Pregnancy Achievement
Effect of a Probiotic on the Female Genital Tract Microbiota of Participants With Fertility Disorders.
Fertility After Uterine Artery Embolization
Biomarkers of Endometrial Receptivity
Sperm Selection by Microfluidic Separation Improves Embryo Quality
Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer
Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.
Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity
Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
Menopur And Rekovelle Combination Study Version 2.0
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
TRAP Study: Testosterone for Androgen Receptor Polymorphism
Uterine Inflammatory Characteristics
Use of Acupressing in Reproductive Medicine
Quantum Natural Family Planning Pilot
Performance of CHLOE Algorithm on the Prediction of Blastocyst Formation